Hepatitis Be antigen (HBeAg) seroconversion is considered the principal short-term goal of antiviral therapy in chronic hepatitis B. To test whether the pre-and per-treatment HBeAg quantitation has a higher predictive value than that of hepatitis B virus DNA (HBV-DNA) quantitation for the outcome of
β¦ LIBER β¦
ChemInform Abstract: Antiviral Therapy for Chronic Hepatitis C: Current Status and Perspectives
β Scribed by Tetsuo Takehara
- Publisher
- John Wiley and Sons
- Year
- 2010
- Weight
- 15 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0931-7597
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Serum HBeAg quantitation during antivira
β
Heijtink, Rudolf A.; Kruining, Johannes; Honkoop, Pieter; Kuhns, Mary C.; Hop, W
π
Article
π
1997
π
John Wiley and Sons
π
English
β 92 KB
π 1 views
ChemInform Abstract: Polyhedral Boranes
β
Igor B. Sivaev; Vladimir V. Bregadze
π
Article
π
2009
π
John Wiley and Sons
β 15 KB
π 1 views
## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a βFull Textβ option. The original article is trackable v